Analyst Profile

Followed by 529 followers
.
Do Kim

Do Kim

Piper Sandler
Wall Street Analyst
#946 out of 8,160 Wall Street Analysts
#2,020 out of 24,427 experts

Success Rate

46%
127 out of 274 transactions made a profit

Average Return

+9.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Do Kim's trades since 2014 and holding each position for 1 Year would result in 46.35% of your transactions generating a profit, with an average return of 9.0% per rating.

Stock Rating Distribution

424Ratings
80.90% Buy
19.10% Hold
0.00% Sell
Distribution of Do Kim's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Bioxcel Therapeutics
(BTAI)
Rating:Buy
Date:May 23, 2019 - May 23, 2020
Return:+387.10%
The most profitable rating made by Do Kim

Do Kim's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Tetralogic Pharma
Jun 26, 2014
Buy
Initiated
$9.00
(1799900.00% Upside)
1Ratings
0%
-56.10%
CYNA
Cynapsus Therapeutics
Aug 16, 2016
Buy
Reiterated
3Ratings
100%
+164.57%
Eledon Pharmaceuticals
Aug 23, 2016
Hold
Reiterated
$1.15
(-54.18% Downside)
2Ratings
0.00%
MDVN
Medivation
Oct 04, 2016
Hold
Assigned
3Ratings
0.00%
AVXS
AveXis Inc
Oct 09, 2016
Buy
Reiterated
1Ratings
100%
+111.50%
Biogen
Feb 21, 2019
Hold
Initiated
$322.00
(7.73% Upside)
2Ratings
0.00%
ObsEva SA
Jul 06, 2020
Hold
Downgraded
$4.00
(2073.91% Upside)
9Ratings
29%
-29.00%
Bioxcel Therapeutics
Aug 17, 2020
Buy
Reiterated
$95.00
(423.99% Upside)
9Ratings
57%
+125.21%
AKCA
Akcea Therapeutics
Sep 01, 2020
Hold
Downgraded
17Ratings
38%
+4.59%
Alnylam Pharma
Apr 30, 2021
Hold
Reiterated
$174.00
(-25.77% Downside)
30Ratings
70%
+19.15%
List of latest recommendations made by Do Kim. Click to expand and see Do Kim's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >